Comparison of diagnostic routines for suspected Alzheimer's disease patients in US–American and German primary care-Reference-Cited by-同舟云学术

Comparison of diagnostic routines for suspected Alzheimer's disease patients in US–American and German primary care

Published:2023-10 Issue:5 Volume:13 Page:269-280
ISSN:1758-2024
Container-title:Neurodegenerative Disease Management
language:en
Short-container-title:Neurodegenerative Disease Management

Author:

Menne Felix¹^ORCID,Grimmer Timo²^ORCID,Schipke Carola G¹^ORCID

Affiliation:

1. Predemtec AG, Rudower Chaussee 29, Berlin, 12489, Germany

2. Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Department of Psychiatry & Psychotherapy, Ismaninger Str. 22, 81675, Munich, Germany

Abstract

Aim: Thorough diagnostics are a prerequisite for the optimal treatment of Alzheimer's disease (AD). Biomarker-based diagnostics are standard in academia, data on practitioners' diagnostic workups is scarce. Materials & methods: Surveys in German and US healthcare providers (HCP) were conducted regarding diagnostics in presumed AD patients. A subsample of 153 German and 88 US professionals was analyzed in detail. Results: Fewer German physicians conduct AD diagnostics themselves compared with US colleagues (67% vs 99%; p < 0.0001). German doctors more often order diagnostics at other institutions (65% vs 45%; p < 0.005). No significant differences were found regarding the type of diagnostics ordered at other institutions. Conclusion: Diagnostic routines for suspected AD patients differ between German and US–American healthcare providers.

Publisher

Future Medicine Ltd

Subject

Neurology (clinical)

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nmt-2023-0023

Reference33 articles.

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

2. Alzheimer's disease

3. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

4. Gauthier S, Rosa-Neto P, Morais J, Webster C. World Alzheimer Report 2021: journey through the diagnosis of dementia, London, England: Alzheimer's disease international (2021). www.alzint.org/resource/world-alzheimer-report-2021/.